| TTM
|
12/31/2025
|
12/31/2024
|
12/31/2023
|
12/31/2022
|
|
|---|---|---|---|---|---|
| Total Revenue
|
1,075,000 | 1,086,000 | 1,138,000 | 1,150,000 | 1,145,000 |
|
Cost of Revenue
|
-751,000 | -758,000 | -784,000 | -792,000 | -800,000 |
|
Gross Profit
|
324,000 | 328,000 | 354,000 | 358,000 | 345,000 |
| Selling, General and Administrative Expenses
|
-255,000 | -265,000 | -295,000 | -310,000 | -349,000 |
|
Research and Development Expenses
|
-63,000 | -67,000 | -70,000 | -73,000 | -82,000 |
| Provision Expense/Write-Back
|
0 | 0 | 2,000 | 1,000 | 1,000 |
| Other Income/Expense, Operating
|
-59,000 | 12,000 | 20,000 | 29,000 | 47,000 |
|
Operating Income/Expenses
|
-380,000 | -320,000 | -343,000 | -353,000 | -383,000 |
|
Total Operating Profit/Loss
|
-56,000 | 8,000 | 11,000 | 5,000 | -38,000 |
| Total Net Finance Income/Expense
|
-29,000 | -14,000 | -20,000 | -17,000 | -11,000 |
| Net Investment Income
|
-4,000 | -4,000 | -3,000 | -8,000 | -9,000 |
| Irregular Income/Expenses
|
-6,000 | -46,000 | -61,000 | -13,000 | -101,000 |
|
Non-Operating Income/Expenses, Total
|
-34,000 | -64,000 | -84,000 | -38,000 | -121,000 |
|
Pretax Income
|
-92,000 | -55,000 | -75,000 | -35,000 | -157,000 |
|
Provision for Income Tax
|
-3,000 | -7,000 | -15,000 | -16,000 | -29,000 |
|
Net Income from Continuing Operations
|
-95,000 | -63,000 | -91,000 | -51,000 | -186,000 |
|
Discontinued Operations
|
-14,000 | -8,000 | -1,000 | -49,000 | -37,000 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
-108,000 | -71,000 | -92,000 | -101,000 | -223,000 |
|
Non-Controlling/Minority Interests
|
0 | 0 | 0 | -1,000 | 2,000 |
|
Net Income after Non-Controlling/Minority Interests
|
-108,000 | -71,000 | -92,000 | -102,000 | -221,000 |
|
Net Income Available to Common Stockholders
|
-108,000 | -71,000 | -92,000 | -102,000 | -221,000 |
|
Diluted Net Income Available to Common Stockholders
|
-108,000 | -71,000 | -92,000 | -102,000 | -221,000 |
| Basic EPS
|
-0.70 | -0.46 | -0.59 | -0.66 | -1.41 |
| Diluted EPS
|
-0.71 | -0.46 | -0.59 | -0.66 | -1.41 |
|
Basic Weighted Average Shares Outstanding
|
146,487.1950 | 154,820.5280 | 154,820.5280 | 154,820.5280 | 156,236.3190 |
|
Diluted Weighted Average Shares Outstanding
|
146,487.1950 | 154,820.5280 | 154,820.5280 | 154,820.5280 | 200,000 |
| Income Statement, Supplemental
|
|||||
|
EBIT
|
-88,000 | -43,000 | -56,000 | -19,000 | -149,000 |
|
EBITDA
|
-52,000 | -7,000 | -14,000 | 23,000 | -86,000 |
|
Normalized EBITDA
|
69,000 | 59,000 | 70,000 | 91,000 | 91,000 |
12/31/2022 - 1/4/2000
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade